These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 815811)

  • 21. Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.
    Jackson JE; Bressler R
    Drugs; 1981 Oct; 22(4):295-320. PubMed ID: 7030708
    [No Abstract]   [Full Text] [Related]  

  • 22. [Behavior of lactate and pyruvate in diabetics treated with a combination of fenformin and sulfonylurea in varying doses. I].
    Lunetta M; Presti C; Mughini MT; Mughini L
    Clin Ter; 1980 Jun; 93(5):525-33. PubMed ID: 6775863
    [No Abstract]   [Full Text] [Related]  

  • 23. HYPOGLYCEMIA INDUCED BY ANTIDIABETIC SULFONYLUREAS.
    Confederat L; Constantin S; Lupaşcu F; Pânzariu A; Hăncianu M; Profire L
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):579-84. PubMed ID: 26204670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment with glibenclamide in maturity-onset diabetes mellitus.
    Persson I; Madsen SN
    Geriatrics; 1971 May; 26(5):182-95. PubMed ID: 5004113
    [No Abstract]   [Full Text] [Related]  

  • 25. [Glibenclamide, a new oral antidiabetic].
    Edlén A
    Lakartidningen; 1972 Jan; 69(4):342-3. PubMed ID: 4622487
    [No Abstract]   [Full Text] [Related]  

  • 26. Sulphonylurea therapy and hypothyroidism.
    Prince RL; Worth GK; Shenfield GM
    Practitioner; 1980 Dec; 224(1350):1287-9. PubMed ID: 7220451
    [No Abstract]   [Full Text] [Related]  

  • 27. A case of chronic liver disease due to tolazamide.
    Nakao NL; Gelb AM; Stenger RJ; Siegel JH
    Gastroenterology; 1985 Jul; 89(1):192-5. PubMed ID: 4007403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypoglycemia caused by oral antidiabetic agents].
    de Baere H; Decraene P; de Leeuw I; Lemmens P; Verhaegen H
    Ned Tijdschr Geneeskd; 1973 Jul; 117(27):1021-4. PubMed ID: 4206176
    [No Abstract]   [Full Text] [Related]  

  • 29. Dual actions of sulfonylureas and glyburide. Receptor and post-receptor effects.
    Gavin JR
    Am J Med; 1985 Sep; 79(3B):34-42. PubMed ID: 3931460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of glibenclamide & chlorpropamide in newly diagnosed maturity onset diabetics.
    Haider Z; Obaidullah S; Fayyaz-ud-Din
    J Pak Med Assoc; 1976 Feb; 26(2):23-6. PubMed ID: 817043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of renal insufficiency on the hypoglycemic action of sulfonylureas. Kinetics of chlorpropamide in a case of nephropathy].
    Pettipierre B; Fabre J
    Schweiz Med Wochenschr; 1972 Apr; 102(16):570-8. PubMed ID: 5019376
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation.
    Ješić MM; Ješić MD; Maglajlić S; Sajić S; Necić S
    Diabetes Res Clin Pract; 2011 Jan; 91(1):e1-3. PubMed ID: 21056492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of a new oral drug in the treatment of diabetes mellitus].
    Lubetzki J
    Diabete; 1971; 19(3):185-90. PubMed ID: 5002990
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prolonged treatment with glibenclamide in various types of diabetic patient].
    Lozano-Castaneda O; Garcia Viveros M; Gomez Peréz FJ; Rull JA
    Prensa Med Mex; 1971 Oct; 36(9):451-5. PubMed ID: 5002035
    [No Abstract]   [Full Text] [Related]  

  • 35. [Incidence and severity of treatment-induced hypoglycemias in diabetics].
    Hasslacher C; Wahl P
    Dtsch Med Wochenschr; 1971 Nov; 96(46):1787-91. PubMed ID: 5000535
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical testing of a sulphonylurea derivative, glibornuride].
    Zöllner N; Dörfler H; Wolfram G
    Dtsch Med Wochenschr; 1972 Jul; 97(29):1083-8. PubMed ID: 4625427
    [No Abstract]   [Full Text] [Related]  

  • 37. [ON TOLAZAMIDE: APROPOS OF A NEW HYPOGLYCEMIC SULFANYLUREA AND OF ACQUIRED SULFANYLUREAU RESISTANCE].
    KLINGER R; DALLECOSTE P
    Minerva Med; 1964 Jul; 55():2237-40. PubMed ID: 14179829
    [No Abstract]   [Full Text] [Related]  

  • 38. SULPHONYLUREA DRUGS IN PREGNANCY.
    MALINS JM; COOKE AM; PYKE DA; FITZGERALD MG
    Br Med J; 1964 Jul; 2(5402):187. PubMed ID: 14153903
    [No Abstract]   [Full Text] [Related]  

  • 39. CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).
    GRINNELL EH; SKILLMAN TG; BARSE R; MOLLER CL
    Curr Ther Res Clin Exp; 1964 Jul; 6():433-41. PubMed ID: 14203273
    [No Abstract]   [Full Text] [Related]  

  • 40. Glibenclamide: a review.
    Drugs; 1971; 1(2):116-40. PubMed ID: 5004340
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.